Orion Pharma (UK) Limited

Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300

Patient Information Leaflet last updated on the eMC: 11/01/2012
PIL Stalevo 200/50/200mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/01/2012 and displayed until Current
Reasons for adding or updating:
  • Introduction of new strength
Updated on 10/09/2010 and displayed until 11/01/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/07/2010 and displayed until 10/09/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 20/04/2010 and displayed until 12/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/09/2009 and displayed until 20/04/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 17/04/2009 and displayed until 16/09/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 05/02/2009 and displayed until 17/04/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/06/2008 and displayed until 05/02/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   entacapone
   levodopa
   carbidopa